- The price on pain. Quinlivan, Beth // BRW;9/6/2001, Vol. 23 Issue 35, p42
Examines key issues and developments relevant to drug prices in Australia. Sales and marketing strategies; Costs of drugs; Drug manufacturing processes; Implications for pharmaceutical companies.
- Roots of success run deep. Buckley, Bruce // Drug Store News;4/29/2002, Vol. 24 Issue 6, p107
Features the Gouverneur, New York-based drug store chain operator, Kinney Drugs Incorporated. Company's sales growth in 2001; Merchandising strategy of Kinney Drugs; Information on the automated prescription dispensing system at Kinney Drugs.
- AstraZeneca predicts top-tier earnings. // Medical Marketing & Media;Nov2003, Vol. 38 Issue 11, p10
Focuses on the optimism of pharmaceutical company AstraZeneca on achievement of sales goals in the U.S. Result of the annual business review; Sales of new drugs.
- Pricing of prescription drugs and its impact on physiciansâ€™ choice behavior. Chen Miao-Sheng; Shih Yu-Ti // Health Care Management Science;Sep2008, Vol. 11 Issue 3, p288
This research presents an analysis of Taiwanâ€™s health care market with the focus on the pricing of prescription drugs and its impact on physiciansâ€™ choice behavior. Since the advent of Taiwanâ€™s national health insurance, with the competent authority being Bureau of National...
- Two billion-dollar chains prosper by staying true to course. Griffin, Marie // Drug Store News;3/26/2001, Vol. 23 Issue 4, p7
Comments on the business operation of drug chain companies Duane Reade and Brooks Pharmacy. Sales posted by the companies; Comparison of their management strategies; Competition between the drug chains; Markets served by the companies.
- Sneezin' season rings up sales. Wilke, Michael // Advertising Age;9/18/1995, Vol. 66 Issue 37, p1
Reports on the efforts of drug companies to woo customers suffering from sneezing allergy due to bad fall weather conditions. Marketing strategies and sales of various drug companies including Glaxo Wellcome, Seldane and several others.
- There's Something About Mary. // Chain Store Age;Dec2001, Vol. 77 Issue 12, p39
Focuses on the plans of Rite Aid President Mary Sammons for the company's drug stores in the U.S. Strategy for increasing sales of generic drugs; Efforts of the company to cut costs.
- Peddling paranoia. Cassels, Alan // New Internationalist;Nov2003, Issue 362, p16
Reports on the business strategies of pharmaceutical companies in selling cures for imaginary diseases in the U.S. Actions taken to convince consumer of the efficacy of the drug; Employment of public relations agencies to increase sales; Concerns over the safety of the drugs.
- Brazilian drugs show signs of health. Salles, Flavio // Chemical Week;11/13/1996, Vol. 158 Issue 44, p44
Focuses on the growth of Brazil's pharmaceutical industry. Increase in sales in 1995; Expansion plans by several drug companies in the country; Pharmacia & Upjohn's strategy for renegotiating licensing contracts with Rhodia Farma; Top drug sellers in Brazil.
- â€˜Unfortunately strong [pipelines] can become weak quickly and vice versa. Sometimes things don't persist.â€™. Krensavage, Michael // Indianapolis Business Journal;11/1/2004, Vol. 25 Issue 34, p48
Reports on the strategy of drug manufacturer Eli Lilly & Co. to combat the declining sales of the company in the U.S. Reduction of unnecessary expenses by retrenching employees; Promotion of the drug Zyprexa; Elimination of research projects with small odds of success.